Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial
Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page
- Check4 days agoChange DetectedThe study’s location listing for “Gūrgaon, India” was normalized to “Gurgaon, India” for two entries, likely correcting diacritic formatting. The page also reflects an update to the site/page “Revision” version.SummaryDifference0.1%

- Check11 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedAdded two location entries: Gūrgaon, India, 122001 and Gūrgaon, India, 122002. Removed Gurgaon, India, 122001 and Gurgaon, India, 122002.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded Gurgaon, India, 122001 and Gurgaon, India, 122002 as new study locations. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check47 days agoChange DetectedThe Indian site entries 122001 and 122002 changed from Gurgaon to Gūrgaon (diacritic included); this is a spelling/diacritic update to the same locations.SummaryDifference0.1%

- Check54 days agoChange DetectedStandardized the city name from Gūrgaon to Gurgaon for two Indian sites (122001 and 122002) in the locations section.SummaryDifference0.0%

Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.